These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The cardiac effects of prostaglandins and their modification by the prostaglandin antagonist N-0164. Allan G; Levi R J Pharmacol Exp Ther; 1980 Jul; 214(1):45-9. PubMed ID: 6993659 [TBL] [Abstract][Full Text] [Related]
3. 6-Keto-prostaglandin E1 is a potent coronary vasodilator and stimulates a vagal reflex in dogs. Panzenbeck MJ; Hintze TH; Kaley G J Pharmacol Exp Ther; 1988 Mar; 244(3):814-9. PubMed ID: 3075239 [TBL] [Abstract][Full Text] [Related]
4. Coronary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with prostacyclin and other prostanoids. Hyman AL; Kadowitz PJ; Lands WE; Crawford CG; Fried J; Barton J Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3522-6. PubMed ID: 356056 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of the chronotropic effects of prostacyclin in the dog: comparison with the actions of prostaglandin E2. Chiba S; Malik KU J Pharmacol Exp Ther; 1980 May; 213(2):261-6. PubMed ID: 6988574 [TBL] [Abstract][Full Text] [Related]
6. Vascular actions of arachidonic acid and its metabolites in perfused mesenteric and femoral beds of the dog. Dusting GJ; Moncada S; Vane JR Eur J Pharmacol; 1978 May; 49(1):65-72. PubMed ID: 350595 [TBL] [Abstract][Full Text] [Related]
7. Interaction between prostacyclin and nitric oxide in the reflex control of the coronary circulation in conscious dogs. Zhao G; Xu X; Ochoa M; Shen W; Hintze TH Cardiovasc Res; 1996 Nov; 32(5):940-8. PubMed ID: 8944825 [TBL] [Abstract][Full Text] [Related]
8. Effect of low dose prostacyclin infusion on blood flow in acutely ischemic canine myocardium. Einzig S; Sotomora R; Rao GH; Gerrard JM; Foker JE; White JG Prostaglandins Med; 1980 Sep; 5(3):209-19. PubMed ID: 6997909 [TBL] [Abstract][Full Text] [Related]
9. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046. Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223 [TBL] [Abstract][Full Text] [Related]
11. Vasodilator actions of prostaglandin 6-keto-E1 in the pulmonary vascular bed. Hyman AL; Kadowitz PJ J Pharmacol Exp Ther; 1980 Jun; 213(3):468-72. PubMed ID: 7193724 [TBL] [Abstract][Full Text] [Related]
12. The influence of prostacyclin on hemodynamic and coronary blood flow in dogs. Teesalu R; Kòrgevee A Biomed Biochim Acta; 1988; 47(10-11):S56-9. PubMed ID: 3073770 [TBL] [Abstract][Full Text] [Related]
13. Transformation of arachidonic acid and prostaglandin endoperoxides by the guinea pig heart. Formation of RCS and prostacyclin. Schrör K; Moncada S; Ubatuba FB; Vane JR Eur J Pharmacol; 1978 Jan; 47(1):103-14. PubMed ID: 338313 [TBL] [Abstract][Full Text] [Related]
14. Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog. Sybertz EJ; Watkins RW; Baum T; Pula K; Rivelli M J Pharmacol Exp Ther; 1985 Jan; 232(1):156-62. PubMed ID: 3917504 [TBL] [Abstract][Full Text] [Related]
15. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs. Fletcher JR; Ramwell PW Circ Shock; 1980; 7(3):299-308. PubMed ID: 7004660 [TBL] [Abstract][Full Text] [Related]
17. Delayed antiischemic effect of prostaglandin I2 and of a new stable prostaglandin I2 analogue, 7-oxo-prostacyclin-Na, in experimental model angina in dogs. Szekeres L; Krassói I; Pataricza J; Udvary E Adv Myocardiol; 1985; 6():607-18. PubMed ID: 3887531 [TBL] [Abstract][Full Text] [Related]
18. Effects of prostacyclin on systemic and coronary hemodynamics in the dog. Mehta J; Nichols WW; Mehta P; Pepine C; Conti CR Am Heart J; 1981 Nov; 102(5):835-40. PubMed ID: 7030040 [TBL] [Abstract][Full Text] [Related]